Search - tctmd.com

Displaying 1 - 20 of 1177

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Todd Neale

December 26, 2016

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

News Daily News

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

L.A. McKeown

December 13, 2016

News Daily News

Conflict Persists Between Guidelines and Practice When It Comes to Treating CAD in TAVR Candidates

Todd Neale

December 08, 2016

News Daily News

Believe It: Mitral Valve Repair Beats Replacement for Severe Regurgitation, Registry Shows

Shelley Wood

December 05, 2016

News Daily News

After a Lull, Cardioband Purchase Represents Latest in Mitral Valve Tech Acquisitions

Shelley Wood

November 30, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

Shelley Wood

November 14, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Ganesh Manoharan

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: SENTINEL

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Alexandra J. Lansky

November 01, 2016

Presentation TCT 2016

The Tricuspid Valve: Challenges for Clinical Investigation

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Transcatheter Pulmonary Valve Replacement 2: Sapien

Presenter: Ziyad M. Hijazi, C. Huie Lin, Eric Horlick

November 01, 2016

Presentation TCT 2016

Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies

Presenter: Matthew G. Hillebrenner, Michael J. Mack, John C Laschinger

November 01, 2016

Presentation TCT 2016

Transcatheter Pulmonary Valve Replacement 1: Melody

Presenter: Ziyad M. Hijazi, C. Huie Lin, John P. Cheatham

November 01, 2016

Presentation TCT 2016

PA Stenting During Transcatheter Pulmonary Valve Replacement Procedures

Presenter: Ziyad M. Hijazi, C. Huie Lin, Lee N. Benson

November 01, 2016

Advertisement

TCTMD’s Top 10 Most Popular News and Features for 2016

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

Conflict Persists Between Guidelines and Practice When It Comes to Treating CAD in TAVR Candidates

Believe It: Mitral Valve Repair Beats Replacement for Severe Regurgitation, Registry Shows

After a Lull, Cardioband Purchase Represents Latest in Mitral Valve Tech Acquisitions

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Highlights (and my Interpretations) From: SENTINEL

The Tricuspid Valve: Challenges for Clinical Investigation

Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened?

Transcatheter Pulmonary Valve Replacement 2: Sapien

Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies

Transcatheter Pulmonary Valve Replacement 1: Melody

PA Stenting During Transcatheter Pulmonary Valve Replacement Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content